Boyer, Paul L.; Rehm, Catherine A.; Sneller, Michael C.; Mican, JoAnn; Caplan, Margaret R.; Dewar, Robin; Ferris, Andrea L.; Clark, Patrick; Johnson, Adam; Maldarelli, Frank; Hughes, Stephen H. published the artcile< A combination of amino acid mutations leads to resistance to multiple nucleoside analogs in reverse transcriptases from HIV-1 subtypes B and C>, Name: (9Z,12Z)-Methyl octadeca-9,12-dienoate, the main research area is abacavir azidothymidine zidovudine antiviral agent drug resistance HIV1 infection.
Resistance to anti-HIV drugs has been a problem from the beginning of antiviral drug treatments. The recent expansion of combination antiretroviral therapy worldwide has led to an increase in resistance to antiretrovirals; understanding the mechanisms of resistance is increasingly important. In this study, we analyzed reverse transcriptase (RT) variants based on sequences derived from an individual who had low-level rebound viremia while undergoing therapy with abacavir, azidothymidine (AZT) (zidovudine), and (-)-L-2,3-dideoxy-3-thiacytidine (3TC) (lamivudine). The RT had mutations at positions 64, 67, 70, 184, and 219 and a threonine insertion after amino acid 69 in RT. The virus remained partially susceptible to the nucleoside RT inhibitor (NRTI) regimen. We show how these mutations affect the ability of NRTIs to inhibit DNA synthesis by RT. The presence of the inserted threonine reduced the susceptibility of the RT mutant to inhibition by tenofovir.
Antimicrobial Agents and Chemotherapy published new progress about Anti-HIV agents. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Name: (9Z,12Z)-Methyl octadeca-9,12-dienoate.
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics